E1m#1 |
E1 |
CRPVE1 sequence 3128–3170bp replaced by corresponding ROPVE1 |
E1m#2 |
|
CRPVE1 sequence 1999–2017 replaced by corresponding ROPVE1 |
E2m#1 |
E2 |
CRPVE2 sequence 4021–4283bp replaced by corresponding ROPVE2 |
E2m#2 |
|
CRPVE2 sequence 3128–3382bp replaced by corresponding ROPVE2 |
E5m#1 |
E5 |
CRPVE5/E8 double ATG mutant with wild type E8 at NsiI |
E5m#2 |
|
CRPVE5 ATG mutant with 314bp fragment of HSV-tk gene in the sense orientation at NsiI |
E5m#3 |
|
CRPV with a deletion of 4300–4344bp in E5 |
E6m#1 |
E6 |
CRPVE6 with new enzyme sites engineered at 326bp/MscI and 476bp/HpaI |
E6m#2 |
|
CRPV E6 and E7 replaced by ROPVE6 and E7 |
E6m#3 |
|
CRPVE6 fragment 326–476bp replaced by corresponding ROPV fragment |
E6m#4 |
|
CRPVE6 fragment 326–973bp replaced by corresponding ROPV fragment |
E6m#5 |
|
CRPVE6 fragment 476–973bp replaced by corresponding ROPV fragment |
E7m#1 |
E7 |
CRPVE7 point mutation resulting in S21 to G |
E7m#2 |
|
CRPVE7 point mutation resulting in S21 to D |
E7m#3 |
|
CRPVE7 point mutation resulting in R57 to S |
E7m#4 |
|
CRPVE7 replaced by CRPV regressive strain E7 |
E7m#5 |
|
CRPVE7 containing HPV16E7/82–90 epitope LLMGTLGIV |
URRm#1 |
URR |
CRPV with 7732–7786 deletion and a mutation in the 8th E2 binding site |
URRm#2 |
|
Replacement of CRPVURR with ROPVURR at engineered enzyme sites BsiW1/7380 and SacII/152 deletion of URR7671–7798 fragment) |
URRm#3 |
|
|
URRm#4 |
|
CRPVURR with four additional E2 binding sites at Bg lII |
URRm#5 |
|
CRPVURR with two copies of ROPVURR 7458–7556bp fragment in sense orientation at BglII |
URRm#6 |
|
CRPVURR with full length of ROPVURR inserted at Bg lII |
URRm#7 |
|
CRPVURR with a deletion of most 5′ E2 binding site 7420–7466bp |
URRm#8 |
|
CRPVURR with insertion of a 314bp fragment of the HSV-tk gene at BglII |
URRm#9 |
|
CRPVURR with two additional E2 binding sites at BglII |
URRm#10 |
|
CRPVURR with six additional E2 binding sites at BglII |